drugset / Trial / NCT01467726

Safety, Pharmacokinetics and Pharmacodynamics of Velusetrag in Healthy Elderly Subjects

NCT01467726 ↗

Phase 1 Completed 40 enrolled Alfasigma S.p.A. Theravance Biopharma · collab
RandomizedParallel-groupDouble-blindTreatment

Summary

This is a Phase 1, Randomized, Placebo-Controlled, Double-Blind, Study of Safety, Pharmacokinetics and Pharmacodynamics of Velusetrag in Healthy Elderly Subjects.

Timeline

Start
2011-11
Primary completion
2012-01
Completion
2012-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Velusetrag Small molecule — —

Indications